Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-May 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 67151000001115 | Glecaprevir 50mg / Pibrentasvir 20mg granules sachets | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module | 
| 67161000001117 | Glecaprevir 50mg / Pibrentasvir 20mg granules sachets (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module | 
| 2253201000001119 | Glecaprevir 50mg / Pibrentasvir 20mg granules sachets sugar free | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module | 
| 2253221000001114 | Glecaprevir 50mg / Pibrentasvir 20mg granules sachets sugar free (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Maviret 50mg/20mg granules sachets (AbbVie Ltd) | Is a | True | Glecaprevir 50mg / Pibrentasvir 20mg granules sachets sugar free | Inferred relationship | Existential restriction modifier | |
| Glecaprevir 50mg / Pibrentasvir 20mg granules sachets sugar free 28 sachet | Has VMP | True | Glecaprevir 50mg / Pibrentasvir 20mg granules sachets sugar free | Inferred relationship | Existential restriction modifier | 
This concept is not in any reference sets